相关实验视频
Updated: Jan 6, 2026

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.9K
洞察神经疾病的分子机制及其病理生理反应
Sharmistha Banerjee1, Parames C Sil2
1Centre for Research in Pure and Applied Sciences, Jain University, Bengaluru, Karnakata, 560078, India.
Archives of toxicology
|September 13, 2025
概括
本综述探讨了神经系统疾病背后的分子机制,从发病到进展,在细胞和分子层面. 它还研究了创造性的运动疗法,以改善神经退行性患者的认知能力.
科学领域:
- 神经科学和分子生物学
- 病理学和治疗学 病理学和治疗学
背景情况:
- 神经系统疾病的起源很古老,但它们的分子机制是通过近几十年的研究来理解的.
- 了解这些机制对于开发有效治疗方法至关重要.
研究的目的:
- 审查神经系统疾病发病和进展背后的分子机制.
- 探索细胞,有机体和金属离子相互作用的作用.
- 讨论用于病理分析的先进显微镜和生化技术.
- 突出创意运动疗法用于神经退行性疾病的认知改善.
主要方法:
- 文献综述专注于分子机制.
- 对细胞,有机体和金属离子作用的分析.
- 集成先进的显微镜和生物化学数据.
- 探索治疗干预的方法.
主要成果:
- 确定了神经疾病发病和进展的详细分子途径.
- 确定了超结构性病理和生化参数之间的相关性.
- 突出了金属离子在疾病发病过程中的作用.
- 演示了创造性运动疗法用于认知增强的潜力.
结论:
- 涉及细胞,器官和金属离子水平的分子机制是神经系统疾病的关键.
- 先进的成像和生物化学分析对于理解病理学至关重要.
- 创意运动疗法为神经退行性患者护理提供了一个有前途的途径.
相关概念视频
Disorders of the Nervous Tissue
2.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.4K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Excitatory and Inhibitory Effects of Neurotransmitters
12.4K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
12.4K
Neurochemical Transmission: Sites of Drug Action
3.4K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.4K
The Blood-brain Barrier
52.1K
Overview
52.1K

